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ABSTRACT: Hydroxylation and ﬂuorination of proline
alters the pyrrolidine ring pucker and the trans:cis amide
bond ratio in a stereochemistry-dependent fashion, aﬀecting
molecular recognition of proline-containing molecules by
biological systems. While hydroxyprolines and ﬂuoroprolines
are common motifs in medicinal and biological chemistry, the
synthesis and molecular properties of prolines containing both
modiﬁcations, i.e., ﬂuoro-hydroxyprolines, have not been
described. Here we present a practical and facile synthesis
of all four diastereoisomers of 3-ﬂuoro-4-hydroxyprolines (F-
Hyps), starting from readily available 4-oxo-L-proline derivatives. Small-molecule X-ray crystallography, NMR spectroscopy, and
quantum mechanical calculations are consistent with ﬂuorination at C3 having negligible eﬀects on the hydrogen bond donor
capacity of the C4 hydroxyl, but inverting the natural preference of Hyp from C4-exo to C4-endo pucker. In spite of this, F-Hyps
still bind to the von Hippel−Lindau (VHL) E3 ligase, which naturally recognizes C4-exo Hyp in a stereoselective fashion. Co-
crystal structures and electrostatic potential calculations support and rationalize the observed preferential recognition for
(3R,4S)-F-Hyp over the corresponding (3S,4S) epimer by VHL. We show that (3R,4S)-F-Hyp provides bioisosteric Hyp
substitution in both hypoxia-inducible factor 1 alpha (HIF-1α) substrate peptides and peptidomimetic ligands that form part of
PROTAC (proteolysis targeting chimera) conjugates for targeted protein degradation. Despite a weakened aﬃnity, Hyp
substitution with (3S,4S)-F-Hyp within the PROTAC MZ1 led to Brd4-selective cellular degradation at concentrations >100-
fold lower than the binary Kd for VHL. We anticipate that the disclosed chemistry of 3-ﬂuoro-4-hydroxyprolines and their
application as VHL ligands for targeted protein degradation will be of wide interest to medicinal organic chemists, chemical
biologists, and drug discoverers alike.
1. INTRODUCTION
(2S,4R)-4-Hydroxyproline (Hyp) is a nonessential amino acid,
prevalently found in collagen and produced by the most
common, irreversible, posttranslational modiﬁcation in ani-
mals: proline hydroxylation.1−3 Introduction of the hydroxyl
group on the ﬁve-membered ring of proline at the 4R position
aﬀects the pyrrolidine ring puckering, shifting the C4-endo
pucker preference of proline to the C4-exo pucker of Hyp.4−6
The C4-exo conformer in Hyp is stabilized by the well-known
gauche eﬀect (Chart 1A).7 This particular conformer allows a
gauche arrangement between the two electronegative sub-
stituents of two vicinal carbons, i.e., the prolyl amide group and
the hydroxyl group (dihedral angle N−C5−C4−O of
approximately 60 degrees).4,5,8 Notably, the C4-exo pucker
conformation places the carbonyl of the i amino acid in the
correct position to interact with the Hyp carbonyl (i + 1),
enabling an n→ π* interaction that in turn stabilizes the trans
amide bond in Hyp-containing peptides and proteins.4,5 As a
result of the gauche eﬀect, conversely, the diastereoisomer
(2S,4S)-4-hydroxyproline (hyp) adopts a C4-endo pucker
conformation, which reduces the n → π* interaction and
leads to a lower trans:cis amide ratio.9 Following similar
considerations, the puckering system for the less common 3-
hydroxyprolines can be explained and predicted.10,11
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The realization that the stereochemistry of electronegative
atoms on proline rings can greatly aﬀect the conformation of
the pucker and the trans:cis amide bond ratio has prompted
the design and synthesis of a diverse array of unnatural proline
derivatives.12 Among these, monoﬂuorinated13,14 and triﬂuor-
omethyl prolines15 have been extensively studied. Fluorination
at C4 or C3 causes stabilization of the C4-endo/C4-exo ring
pucker in a similar fashion to hydroxylation, according to the
same gauche eﬀect.13,14 To this end, 4-ﬂuoro and 3-ﬂuoro
prolines have been incorporated in proteins such as collagen,16
ubiquitin,17 and GFP,18 used to probe prolyl isomerase enzyme
activity by NMR19 and used as PET probes.20 Beyond
proteins, ﬂuorinated prolines have also found applications as
building blocks for medicinal chemistry,21 reﬂecting the wide
interest in ﬂuorination as a strategy to ﬁnely tune conforma-
tional and physicochemical properties of biologically active
small molecules and peptides.22−25 For instance, the
incorporation of (4S)- or (4R)-4-ﬂuoroprolines into inhibitors
of ﬁbroblast activation protein (FAP)26 and thrombin27 (Chart
1B) stabilizes a single conformational pucker of the pyrrolidine
ring (the C4-endo in the case of FAP inhibitor and the C4-exo
for thrombin inhibitor), which results in improved potency
compared to the unsubstituted proline analogues. More
recently, mono- and diﬂuorinated prolines were discovered
to enhance key CH/π interactions in peptide−protein
complexes.28 Like ﬂuorinated prolines, hydroxyprolines are
common building blocks in medicinal chemistry: the Hyp core
can be found in the structure of recently FDA approved
inhibitors of the NS3-4A serine protease such as glecaprevir29
(Chart 1B). Curiously, despite the variety of ﬂuorinated and
hydroxylated proline derivatives reported in the literature, the
simultaneous presence of these two modiﬁcations within the
same pyrrolidine ring is unprecedented. Introduction of
ﬂuorine substituents can modulate the electronic and
conformational properties of small molecules, thus impacting
protein−ligand and protein−protein binding aﬃnities, as well
as metabolism and cell permeability.21 We therefore became
interested in exploring the synthesis and stereoelectronic
properties of ﬂuorinated hydroxyprolines, which we call F-
Hyps (Chart 1C). We hypothesized that the addition of the
highly electronegative F atom adjacent to the hydroxyl group
on the pyrrolidine ring could signiﬁcantly alter the puckering
preference of the ring and aﬀect the cis:trans amide ratio.
Moreover, it was anticipated that ﬂuorination of hydroxypro-
line would ﬁne-tune the acidity, nucleophilicity, and hydrogen-
bond properties of the hydroxyl group, depending on the
stereochemistry of the ﬂuorine atom. To this end, previous
reports have studied the inﬂuence of ﬂuorine on the −OH
group acidity in the context of 2-ﬂuorocyclohexanols and have
shown that ﬂuorination can lead to a reduction of alcohol H-
bond acidity as a result of intramolecular F···HO inter-
actions.30
Beyond its structural role in collagen, Hyp has a central role
in oxygen sensing, a biological process of fundamental
physiological and therapeutic relevance.31 Speciﬁcally, hydrox-
ylation of the hypoxia-inducible factor 1 alpha (HIF-1α)
subunits at two conserved proline residues (Pro402 and
Pro564 in HIF-1α), which is catalyzed primarily by the prolyl
hydroxylase enzyme PHD2 (also known as EGLN1),32,33
triggers the binding of HIF-1α to the von Hippel−Lindau
(VHL) Cullin RING E3 ubiquitin ligase (Figure 1A). This
recognition event leads to HIF-1α polyubiquitylation by the
VHL ligase complex and subsequent proteasomal degradation
under normal oxygen levels, preventing the transcription of
hypoxia response genes.34−36 Work from our laboratory and
others leveraged the highly speciﬁc molecular recognition of
Hyp by the VHL E3 ubiquitin ligase (Figure 1B) to design and
develop potent small-molecule VHL ligands.37−41 In one
application, VHL ligands work in their own right as disruptors
Chart 1. Chemical Structures of Hydroxyl- and Fluoro-
prolines: (A) Conformational Preferences of 4-Substituted
Hydroxyprolines and Fluoroprolines; (B) Examples of 4-
Fluoro- and 4-Hydroxyprolines in Medicinal Chemistry;
(C) 3-Fluoro-4-hydroxyprolines (F-Hyps), the Object of
This Study
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of the VHL-HIF protein−protein interaction to block the
ubiquitination of HIF-1α downstream of HIF hydroxylation.
This blockade leads to HIF-1α stabilization in cells, triggering a
hypoxic response under otherwise normoxic conditions
(Figure 1A).39−41 In a distinct application, VHL ligands
provide suitable drug-like starting points for conjugation into
bivalent degrader molecules, also known as proteolysis-
targeting chimeras (PROTACs), which hijack the VHL E3
ligase activity to trigger ubiquitination and degradation of
speciﬁc target proteins.42−44 Many potent and selective Hyp-
based PROTACs have been recently reported against a wide
range of target proteins, including Brd4,45,46 RIPK2,47 c-Abl
kinase,48 VHL itself,49 TBK1,50 and TRIM2451 among others.
A notable example among the ﬁrst to be disclosed is MZ1
(Figure 1C), a potent and selective degrader for the
bromodomain and extra-terminal (BET) protein Brd4 with
profound antiproliferative activity in acute myeloid leukemia
cells.45,46 Our crystal structure of MZ1 bound in a ternary
complex with VHL, elongin B, and elongin C (hereafter called
VBC), and the bromodomain of the target protein Brd4
revealed a structural basis for the cooperative ternary complex
recognition that underpins the mode of action of the degrader
molecule.52 The design of bivalent degrader molecules is
seeing increasing interest for drug development, due to their
catalytic rather than occupancy-based mode of action and an
extended duration of action at low concentrations in
substoichiometric fashion.53 All current VHL-targeting de-
graders contain Hyp as the core building block. It would
therefore be of interest and potentially beneﬁcial to replace
Hyp with novel scaﬀolds, for example by introducing
substitutions that might ﬁne-tune the molecular recognition
and pharmacokinetic properties of the ﬁnal compounds.
Here we describe the synthesis of novel F-Hyps. We
developed synthetic routes that allow eﬃcient and robust
synthesis for all four possible diastereoisomers and extensively
studied their conformational and stereoelectronic properties
using NMR spectroscopy, X-ray crystallography, and computa-
tional approaches. The simultaneous presence of F and OH on
the proline ring was found to aﬀect the conformational and
electronic properties of the amino acid, which could be
rationalized by means of small-molecule crystal structures and
quantum mechanics calculations. Finally, to provide a proof-of-
concept for the application of F-Hyps as building blocks to
probe biology, we systematically incorporated F-Hyps in place
of Hyp into a diverse set of HIF-1α peptides, VHL ligands, and
VHL-targeting PROTACs and investigated the eﬀect of
ﬂuorination of Hyp on VHL binding. We found that VHL
exhibits a highly stereoselective recognition of the (3R,4S)-3-
ﬂuoro-4-hydroxyproline over the (3S,4S) epimer. We show
that (3R,4S)-3-ﬂuoro-4-hydroxyproline incorporation achieved
ligands and PROTACs with aﬃnities and cellular activities
comparable to those of the parent Hyp-containing compounds,
while incorporation of the (3S,4S) epimer led to Brd4-selective
degradation at nanomolar concentration in spite of a loss of
∼20-fold binding aﬃnity to VHL.
2. RESULTS AND DISCUSSION
2.1. Chemistry. To prepare the desired 3-ﬂuoro-4-hydroxy
prolines, we envisaged a synthetic strategy based on electro-
philic ﬂuorination of an enolate or enolate equivalent of N-
Boc-4-oxo-L-proline benzyl ester 1, which is known to be
regioselectively enolized at the C3 under kinetic conditions.54
In a ﬁrst set of experiments, the lithium, sodium, and
potassium enolate of 1, generated by treatment of ketone 1
with the corresponding metal hexamethyldisylazides at −78 °C
in tetrahydrofuran (THF), were reacted with N-ﬂuorobenze-
nesulfonimide at −78 °C, and the reaction mixtures were
allowed to slowly warm to room temperature overnight. In all
cases, no ﬂuorinated ketone was detected by 19F NMR, and
complex reaction mixtures were obtained. We next attempted
to prepare the trimethylsilyl enol ether 2 (Scheme 1) by
quenching the lithium enolate of 1 with trimethylsilyl chloride,
as described previously.54 Silyl enol ether 2 was isolated by
pentane extraction and, after solvent removal, directly reacted
Figure 1. von Hippel-Lindau E3 ligase recognition of Hyp for VHL ligands and PROTACs. (A) Schematic representation of the VHL E3 ligase
recognition and ubiquitylation of the endogenous substrate, inhibition of the catalytic activity of VHL by blocking the substrate recognition site,
and PROTAC-induced targeted protein ubiquitylation by VHL hijacking. (B) Hyp-binding site with key polar interactions between VHL and Hyp
in a C4-exo, trans amide conformation. (C) Examples of VHL inhibitors and VHL-based PROTACs built around the essential Hyp core.
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with Selectﬂuor in acetonitrile at −30 °C. The reaction mixture
was allowed to slowly warm to room temperature overnight,
and we were pleased to observe a set of 19F NMR signals
compatible with a diastereoisomeric mixture of ﬂuorinated
ketones 3a,b in a ∼1.5:1 ratio and 50% overall isolated yield.
However, variability of yield and diastereoisomeric ratio was
observed when scaling up this reaction, with considerable
reduction of yield when the ﬂuorination was performed in
gram scale. As a reliable ﬂuorination protocol was highly
desirable, a ﬂow chemistry approach was considered. No
examples of ﬂuorination of silyl enol ether in ﬂow conditions
were found in the literature, except for a closely related α-
ﬂuorination of activated carbonyl compounds with Selectﬂuor,
reported by the Ley laboratory in 2009.55 Under optimized
conditions, the silyl enol ether 2 and Selectﬂuor were dissolved
in anhydrous acetonitrile (0.67 and 0.1 M, respectively) and
pumped at a rate of 0.77 mL/min in a 10 mL ﬂow reactor
(residence time 6.5 min) heated at 50 °C. The mixing was
provided by a T piece junction before the coiled reactor. The
crude product was treated with a saturated solution of NH4Cl
and ﬁltered over a short silica column, providing the
ﬂuorinated ketones 3a,b in a ∼1:1 ratio and 55% isolated yield.
Because any attempt to separate the diastereoisomers by
column chromatography failed, we decided to subject the
diastereoisomeric mixture to sodium borohydride reduction.
Three ﬂuorohydrines were isolated, 4a in 58%, 4b in 30%, and
4c in 11% yield. Despite being complicated by the well-known
conformational isomerism shown by N-Boc prolines, the 1H
NMR spectra of 4a, 4b, and 4c in CDCl3 showed remarkable
diﬀerences in the coupling constants between H2 and H3 (see
Figure 2A for numbering of the proline ring): JH2−H3 = 5.9 Hz
in 4a and close to zero in 4b and 4c. This observation
suggested that in 4a the ﬂuorine atom and the carboxylate may
be present in a cis conformation, in which the angle between
Scheme 1. Synthesis of F-Hyps N-Protected Amino Acids
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H2 and H3 is consistent with a relatively large JH2−H3 value. On
the other hand, the JH2−H3 value observed for 4b and 4c
suggests an angle between H2 and H3 around 90°, possible
when the ﬂuorine atom and the carboxylate arrange in a trans
conformation. The stereochemistry of the main products 4a
and 4b was unequivocally assigned by means of NOESY and
19F-detected 19F−1H HOESY NMR experiments (Figure 2A).
In the case of 4a, the relative intensities of NOESY peaks for
H2−H3 and H3−H4 were consistent with a cis arrangement of
H2−H3−H4 (Figure 2A). The relative intensity of the 19F−1H
HOESY peaks for H2−F and H4−F were equally low and
compatible with a trans arrangement of the F atom with both
H2 and H4. For 4b, a cis arrangement could be deduced only
for H3−H4, as the intensity of the NOESY peak for H2−H3 was
40% lower than the one for H3−H4 (Figure 2A). Consistently,
the relative intensity of the 19F−1H HOESY peaks for H2−F
was 87% higher than the one for H4−F, conﬁrming a cis
arrangement between H2−F and a trans relationship between
H4−F (Figure 2A). These observations reveal that the main
products of the reduction, 4a,b, result from a hydride delivery
anti to the ﬂuorine atom. This same preference had previously
been observed in the reduction of conformationally locked
ﬂuorocyclohexanones.30
Mitsunobu esteriﬁcation of 4a and 4b with 4-nitrobenzoic
acid was conducted, followed by deprotection by sodium azide
in methanol.56 This allowed access to the fourth diaster-
eoisomer (4d) when starting from 4a and to a product
identical to 4c when starting from 4b. These results conﬁrmed
that the minor product of the borohydride reduction, 4c, is the
epimer at the C4 of 4b. As expected, for the newly synthesized
compound 4d, the coupling constant between H2 and H3 (5.2
Hz) is very similar to its C4 epimer 4a. The stereochemical
assignment of 4a−c was also conﬁrmed by X-ray diﬀraction of
the isolated products (Figure 2B and Supp. Figures 3−5).
Interestingly, 4a,b crystallized with a cis carbamate conﬁg-
uration (similarly to a previously reported N-Boc proline
derivative9), whereas 4c crystallized with a trans carbamate
conﬁguration. For the (4R) derivatives 4a and 4c no
transannular hydrogen bond between the carboxylate and the
hydroxyl group was found. Finally, catalytic hydrogenation of
the benzyl esters 4a−d aﬀorded the Boc-protected amino acids
6a−d in good yield and suﬃcient purity to be used for further
synthetic steps.
With the aim to develop a stereoselective synthesis, and
inspired by previous work on the synthesis of kainic acid
analogues,57 the ﬂuorination step was attempted on the 9-
phenyl ﬂuorenyl (Pf)-protected silyl enol ether 8, prepared
from ketone 7, trimethylsilyl triﬂate, and triethylamine in
dichloromethane (DCM) at −40 °C. Treatment of the silyl
enol ether 8 with Selectﬂuor in acetonitrile at −20 °C aﬀorded
the ﬂuorinated ketone 9 as a sole diastereoisomer in 50% yield.
1H NMR analysis revealed a coupling constant between H2 and
H3 = 8.0 Hz, similar to that of previously reported, structurally
related, cis derivatives.57−60 The stereochemical outcome of
Figure 2. Structural assignment of F-Hyps. (A) Numbering of the F-Hyp ring and stereochemical assignment for 4a,b by NMR (NOESY values of
cross-peaks in black, 19F−1H HOESY values of cross-peaks in blue). (B) Molecular structure of compounds 4a−c and 10 showing 50%
displacement ellipsoids resulting from small-molecule X-ray crystallography.
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the ﬂuorination was in contrast with the observations made on
the alkylation of the same ketone by Zanato et al.,57 which
mainly occurred from the less hindered face of the enolate 8.
Subsequent reduction with sodium borohydride in ethanol/
THF exclusively aﬀorded the all-cis F-Hyp 10. The stereo-
chemistry of compound 10 was conﬁdently assigned by means
of NMR experiments. The relative intensity of NOESY peaks
for H2−H3 and H3−H4 were compatible with a cis arrange-
ment of H2−H3−H4, and the relative intensity of the 19F−1H
HOESY peaks for H2−F and H4−F (equally low) were
compatible with a trans arrangement of the F atom with H2
and H4. Moreover, a coupling constant of JH2−H3 = 8.7 Hz in
10 was found, in accordance with the cis derivatives previously
prepared.57−60 This assignment was subsequently conﬁrmed by
X-ray diﬀraction of 10, which crystallized with a transannular
hydrogen bond between the carboxylate and the hydroxyl
groups (Figure 2B). Mitsunobu esteriﬁcation of 10 with 4-
nitrobenzoic acid followed by treatment with lithium
hydroxide led to the inverted alcohol, and no methyl ester
hydrolysis was observed. Accordingly, the relative intensity of
the 19F−1H HOESY peak for H2−F was compatible with a
trans arrangement, whereas the intensity for H4−F was only
compatible with a cis arrangement, being 150% higher than
that of H2−F. Deprotection of the carboxylate could be
achieved only after removal of the Pf group. To this end, 11
was ﬁrst treated with 5% triﬂuoroacetic acid (TFA) in DCM in
the presence of triisopropylsilane as carbocation scavenger,
then with LiOH at 0 °C in water. To obtain F-Hyps building
blocks, useful for further manipulations, the free F-Hyps were
transformed into the Boc- or Fmoc-protected amino acids by
reaction with Boc- or Fmoc-N-succinimidyl carbonate and
sodium bicarbonate in aqueous dioxane, respectively.
2.2. Conformational Analysis and H-Bond Donor
Capacity of F-Hyps. Recognition of Hyp by VHL is highly
stereoselective and conformation-dependent: the C4-exo ring
pucker of Hyp is essential to locate the hydroxyl group within a
well-deﬁned hydrogen-bond network in the Hyp-binding
pocket. Additionally, binding of HIF-1α peptides and VHL
ligands requires adoption of a trans conformation of the prolyl
tertiary amide (Figure 1B). We therefore became interested in
determining to what extent addition of the highly electro-
negative F atom adjacent to the hydroxyl group in Hyp would
impact the C4-exo ring pucker of the pyrrolidine, aﬀect the
donor capacity of the adjacent hydroxyl group, and modulate
the abundance of trans prolyl amide. We hypothesized that
modulation of these conformational and molecular properties
could signiﬁcantly ﬁne-tune the binding aﬃnity to VHL and
consequently be exploited for a novel class of VHL ligands.
We ﬁrst studied both experimentally and computationally
the conformational preferences of N-acetylproline methylesters
12a−d (Chart 2), extending the analysis to the (3R,4R)- and
(3S,4R)-3-ﬂuoro-4-hydroxyproline derivatives. Analogous
Chart 2. Chemical Structure of F-Hyps 12a−d and the Corresponding Reference Compounds
Table 1. Summary of Conformational Analysis, Second-Order Perturbation Energies, and H-Bond Donor Capacity of F-Hyps
12a−da
compound
ratio
trans:cisb
JH2−H3
(Hz)
calculated
JH̅2−H3 (Hz) optimized ring pucker
rel. E of conformer
(kcal/mol)
fraction of
conformer (%)c
̅ π→ *=En
(2)
O C O
(kcal/mol)d
̅ π→ *=En
(2)
O C O
(kcal/mol)e
V̅a(r)
(a.u.)f
12a 89:11 4.6 5.7 twisted C2-endo−C3-exo 0.8 12 0.8 1.1 0.339
C4-endo (with
transannular H-Bond)
0.1 40
C4-exo 0.0 47
12b 85:15 2.4 1.2 C4-endo 0.0 92 1.0 - 0.378
twisted C3-endo−C4-exo 1.4 8
12c 71:29 <0.5 0.1 C4-endo 0.0 78 0.9 - 0.357
C4-endo (with
transannular H-Bond)
0.8 21
twisted C3-endo−C4-exo 2.7 1
12d 87:13 4.9 7.0 C3-exo 0.0 60 0.4 1.7 0.375
C5-endo 0.2 40
aDFT calculations were carried out at the MN15-L/aug-cc-pVTZ(-F) level of theory in a water solvation continuum. See Supp. Table 3 for full
results. bMeasured as the ratio of proton-decoupled 19F NMR signals in D2O.
cBoltzmann population obtained from relative E. dCharge transfer
from acetyl O lone pair to π* orbital in the carbonyl in C2. eCharge transfer from F lone pair to π* orbital in the carbonyl in C2. fThe Kenny
electrostatic potential correlates with H-bond donor capacity.30,61
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methylesters have been previously used in the literature as
reliable model compounds to study the conformational
preferences of the (4R)-hydroxyproline (Hyp), (4S)-hydrox-
yproline (hyp), (3S)-ﬂuoroproline (3-Fpro), and (3R)-
ﬂuoroproline (3-fpro) moieties.5,13 The compounds 12a−d
were synthesized from 6a−d by (trimethylsilyl)diazomethane
esteriﬁcation, followed by Boc deprotection and N-acetylation.
To predict molecular properties of compounds in solution, we
performed density functional theory (DFT) calculations of
trans C4-endo and exo puckers of 12a−d and the reference
compounds Ac-Hyp-OMe, Ac-hyp-OMe, Ac-3-Fpro-OMe,
Ac-3-fpro-OMe, and Ac-Pro-OMe (Chart 2). All calculations
were carried out at the MN-15L/aug-cc-pVTZ(-F) level of
theory in a water solvation continuum (see Computational
Methods and Supp. Table 1 for details on the choice of density
functional). The protocol correctly anticipates the ring pucker
preferences of model compounds Ac-Pro-OMe, Ac-3-Fpro-
OMe, and Ac-Hyp-OMe and predicts JH2−H3 couplings for Ac-
Hyp-OMe, Ac-hyp-OMe, and F-Hyps 12a−d in excellent
agreement with the corresponding NMR-observed shifts
(Table 1 and Supp. Table 3).
Analysis of the abundance of C4-endo and exo ring puckers
in F-Hyps 12a−d revealed that conformational preferences
upon 2,3-trans ﬂuorination are driven by the stabilizing gauche
conformation between the N and the F atoms. Indeed, 2,3-
trans ﬂuorination of Ac-hyp-OMe to yield 12c further
stabilizes the C4-endo pucker of hyp (99% abundance),
whereas 2,3-trans ﬂuorination of Ac-Hyp-OMe to yield 12b
Figure 3. Topological and conformational analysis and H-bond donating capacity of F-Hyps. NCI isosurface plots for 12a (A) and 12d (B).62
Reduced density gradient shown at an isovalue of 0.3, with interaction strength colored red (attractive), white (van der Waals contact), and blue
(repulsive), ranging from −0.02 to 0.05 a.u. (C) Visualization of the H-bond donor capacity and major conformers of 12a−d, Ac-Hyp-OMe, and
Ac-hyp-OMe. The Kenny electrostatic potential (Vα(r)) correlates with the H-bond donor capacity of the OH.
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shifts the natural preference of hyp from C4-exo to C4-endo
(92% abundance). The case of 2,3-cis ﬂuorination of
hydroxyproline was found to be more complex. The steric
congestion surrounding C3 in 3-fpro has been invoked to
justify the reduced conformational preference of the ring for
either pucker.13 Consistently, F-Hyps 12a and 12d showed
very modest preference to adopt a C4-endo or -exo ring pucker,
with ∼50% abundance of each (ΔEendo/exo < 0.25 kcal/mol).
Noncovalent contacts in the molecules were studied by
topological noncovalent interactions (NCI) analysis62 of the
electron density distribution. In 12a, the NCI study showed a
transannular H-bond between the hydroxyl group and the
carbonyl O in C2, along with a consistent van der Waals
contact between the hydroxyl proton and the ring in 12a. In
contrast, in 12d, NCI analysis detected attractive F···CO
contacts (Figure 3A and B). The ring pucker of the predicted
major components of F-Hyps 12a−c was captured in the
related crystallized compounds 4a−c using small-molecule X-
ray crystallography (Figure 2 and Supp. Figure 1), providing
further support for the theoretical calculations. Taken together,
the conformational analysis revealed that ﬂuorination of Ac-
Hyp-OMe to yield (3R,4S)- and (3S,4S)-3-ﬂuoro-4-hydrox-
yprolines 12b and 12d stabilizes a C4-endo pucker and
consequently would be expected to lower the population of the
desired C4-exo ring pucker required for binding to VHL.
To quantify the energetic extent of the potential nO→ πCO*
charge transfer in F-Hyps 12a−d, we next performed natural
bond order (NBO) analyses.63 This nO → πCO* interaction is
known to stabilize the trans conformer of the amide,64 which is
critical for binding of Hyp to VHL.65 We compared the nO →
πCO* charge transfer energies with the trans:cis ratio of F-Hyp
derivatives 12a−d (observed by 19F NMR) and of 4-
hydroxyprolines and 3-ﬂuoroprolines reported in the liter-
ature13 (Table 1 and Supp. Table 3). The computational and
experimental values for Ac-Hyp-OMe and Ac-hyp-OMe were
in good agreement (higher charge transfers are indicative of
higher abundance of the trans conformer). Instead, the
trans:cis ratio for F-Hyps 12a−d did not correlate with nO
→ πCO* energies. This has been also reported in 3-
ﬂuoroproline,9 suggesting that a combination of other factors,
including inductive and steric eﬀects, might be involved. A
higher amount of cis amide was observed by NMR for 12b,c,
featuring the ﬂuorine atom in the 3-(R) position, compared to
12a,d, bearing the ﬂuorine atom in the 3-(S) position. This
correlates well with the trans:cis ratio experimentally measured
for 3-ﬂuoroprolines.13 Based on the observed trans:cis ratio in
12b,d by NMR, we conclude that ﬂuorination of Hyp does not
stabilize the trans amide conformer, which would otherwise be
expected to enhance the aﬃnity of VHL ligands.
We then became interested in assessing whether ﬂuorination
could lead to a strengthening of the H-bond network of Hyp in
the recognition site of VHL through inductive eﬀects. To
address this question, we calculated the weighted electrostatic
potential V̅α(r) of F-Hyps 12a−d, evaluated at a distance of
0.55 Å from the hydroxyl hydrogen atom along the O−H bond
(Table 1 and Figure 3C).57 This descriptor correlates linearly
with relative H-bond acidity (pKAHY), which is a measure of
the H-bond donor capacity of the hydroxyl group.30,66 An
increase in H-bond donor capacity in Hyp could be potentially
exploited to strengthen its H-bond with His115 (Figure 1B).
However, ﬂuorination of Ac-Hyp-OMe to yield 12b and 12d
induced only a modest increase in the H-bond acidity of the
hydroxyl H atom, regardless of the stereochemistry in C3. This
suggests that the inductive eﬀect of the ﬂuorine may compete
with a transannular H-bond to the F atom in the
compounds.30,67 Nonetheless, we observed relatively long F···
H−O distances (2.5−3.3 Å) along with undetectable n → σ*
charge transfer between the lone pairs in the F and the
acceptor σOH* orbital, as by NBO analysis. Topological
analysis of electron densities using NCI did not reveal any F···
H−C contact, either. Thus, capture of the proton in 12b and
12d may arise from a weak electrostatic stabilization rather
than a typical H-bond.30 Together, these analyses indicate that
C3 ﬂuorination of Hyp may only modestly improve the H-
bond donor capacity of the hydroxyl group, regardless of the
stereochemistry in C3. For completeness, we also studied the
proton acidity of Ac-hyp-OMe and its ﬂuoro derivatives 12a
and 12c. A substantial decrease in H-bond donor capacity of
the hydroxyl group in Ac-hyp-OMe compared to Ac-Hyp-
OMe was anticipated, since in Ac-hyp-OMe the hydroxyl
group engages in a transannular H-bond with the carbonyl O
in C2. Fluorination of Ac-hyp-OMe to form 12a and 12c
induces a higher increase in H-bond donor capacity compared
to ﬂuorination of Ac-Hyp-OMe, suggesting that in those
compounds the inductive eﬀect of ﬂuorine is not competing
with an F···H−O contact. The increase in acidity is utmost
notorious in 12c, in which the ﬂuorine atom is antiperiplanar
to the O. Indeed, it has been proposed that this arrangement
increases the electronegativity of the ﬂuorine.30 The increasing
acidity of the protons (Ac-hyp-OMe < 12a < 12c) can be
further rationalized by the decreasing fraction of transannular
H-bond (Ac-hyp-OMe > 12a > 12c, Figure 3C), which at the
same time is consistent with an increase in the H-bond
distance. Additional topological analyses of electron densities
and second-order perturbation energies were also consistent
with a weakening of the transannular H-bond upon
ﬂuorination of Ac-hyp-OMe, particularly in 12c (Supp.
Table 4). Thus, C3 ﬂuorination of Hyp and hyp has a distinct
impact on proton acidity. In Hyp the inductive eﬀect of F is
compensated by a weak electrostatic stabilization of the H
atom. In contrast, in hyp the acidity increases in a
stereoselective fashion assisted by a weakening of the
transannular H-bond.
Taken together, the conformational analysis of F-Hyps
12b,d indicates that C3-ﬂuorination of Ac-Hyp-OMe,
irrespective of the relative stereochemistry, does not modulate
conformational preferences and hydrogen-bonding potential of
the Hyp core fragment in the directions that would be
expected to strengthen the binding aﬃnity of VHL ligands.
First, we do not observe stabilization of the C4-exo ring pucker,
which is critical for recognition (Figure 1B). Rather, we
observe a preference for the C4-endo pucker in both 12b and
12d, albeit to varying extent. Second, we do not detect an
increase in the abundance of the trans amide conformer by
NMR, which is required for binding to VHL. And third,
ﬂuorination induces only a very minor increase in the H-bond
donor capacity of the hydroxyl group, regardless of the
stereochemistry in C3. Nevertheless, ﬂuorine often participates
in noncanonical ligand−protein interactions that cannot be
inferred from studying the isolated ligand and that generally
behave in a highly nonadditive fashion, making it diﬃcult to
predict them computationally. We therefore decided to
proceed to interrogate the molecular recognition of F-Hyp-
containing peptides and peptidomimetics by VHL experimen-
tally.
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2.3. Synthesis and Biophysical and Structural Binding
Studies of F-Hyp-Containing Peptides of HIF-1α. Hyp-
containing HIF-1α epitope peptides are excellent model
substrates for studying the binding to VHL, as their binding
mode and aﬃnities have been extensively characterized.32,33,37
To assess to what extent VHL recognizes F-Hyps as an
artiﬁcial post-translational modiﬁcation of proline, modiﬁed
peptides from the C-terminal oxygen-dependent degradation
domain of HIF-1α (of sequence DEALA(Hyp)-
YIPMDDDFQLRSF) that contained (3S,4S)- or (3R,4S)-F-
Hyps in place of Hyp were synthesized (Chart 3).
To this end, Fmoc-protected (3S,4S)- and (3R,4S)-F-Hyps
were prepared from the corresponding Boc-protected amino
acids 6b and 6d via acidic deprotection of the Boc group
followed by Fmoc installation by reaction with Fmoc-OSu.
The ﬁrst 13 C-terminal amino acids (YIPMDDDFQLRSF) of
the 19-mer peptides were coupled via conventional automated
solid-phase peptide synthesis on a Rink amide resin before the
N-Fmoc-protected F-Hyps were manually coupled to resin-
bound peptide via HATU/HOAT coupling. After Fmoc
deprotection of F-Hyps, peptide elongation was performed
manually, the N-terminal Fmoc group was removed, and the
peptides were cleaved from the resin using a TFA/
triisopropylsilane/H2O (95:2.5:2.5) mixture. The crude
peptides were puriﬁed by preparative HPLC to obtain the
epimeric peptides 13a,b. The corresponding peptides contain-
ing the (3S,4R)- and (3R,4R)-F-hyp were not prepared
because it is well-known that such stereochemical arrangement
of the hydroxyl group is not tolerated in the VHL binding site.8
Binding of the modiﬁed F-Hyp-containing peptides 13a,b to
VBC was assessed using isothermal titration calorimetry (ITC,
Figure 4A). Both peptides 13a,b presented nanomolar binding
aﬃnity to VBC (Kd = 12 ± 2 nM and 52 ± 3 nM, respectively,
Table 2). Remarkably, 13a showed comparable binding aﬃnity
to the native peptide 13c (prepared as previously reported),37
for which a Kd = 11 ± 1 nM was measured (Table 2). Among
the ﬂuorinated peptides, 13a, containing the (3R,4S)-F-Hyp
isomer, showed a 4-fold higher aﬃnity for VBC than 13b,
suggesting that VHL can recognize F-Hyps in a diastereose-
lective fashion.
To elucidate the binding mode of F-Hyp-containing HIF
peptides, we solved the cocrystal structure of the ternary
complex VBC with peptide 13a (to a resolution of 1.8 Å) and
compared it to the cocrystal structure of the native peptide
13c.37 The VBC:13a complex crystallized in the same space
group as VBC:13c (P43212), and the overall unit cell
parameters and crystal packing were conserved. The F-Hyp-
containing peptide 13a was found to adopt an identical
binding mode when compared to the native peptide 13c
(Figure 4B) and other HIF peptides,32,33 with all hydrogen
bonds being conserved. After structural reﬁnement, the
pyrrolidine ring of the (3R,4S)-F-Hyp residue was modeled
in a C3-endo conformation, as this satisﬁed better the extra
electron density. However, the resolution was not suﬃciently
high to exclude the possibility of a C4-exo pucker, which was
observed in the case of the cocrystal of VBC:13c, as the
conformational diﬀerence between the two states (C3-endo
and C4-exo) is very subtle. In the bound state, the hydroxyl
group of the 13a F-Hyp forms two key hydrogen bonds to the
side chains of His115 and Ser111, exactly as observed for Hyp
in the native peptide 13c (Figure 4B). The newly introduced
ﬂuorine atom forms close contacts with an aromatic C−H of
the indole ring of Trp117 (3.3 Å), the hydroxy group of Ser111
(3.2 Å), and the carbonyl of His110 (3.2 Å). An overlay of the
VHL-cocrystallized peptide 13a with the small-molecule crystal
structure of F-Hyp 4b (Figure 4C) reveals that, in order to
preserve the key H-bond network of the Hyp core, the F-Hyp
Chart 3. Structures of Model HIF-1α Peptides Biophysically
Evaluated in This Work
Figure 4. Binding aﬃnity and binding mode of F-Hyp-containing
HIF-1α peptides. (A) Overlay of ITC titration curves obtained for F-
Hyps-containing peptides 13a,b against VBC. (B) Crystal structure of
peptide 13a (blue) in complex with VBC (green) overlaid with the
structure of VBC in complex with the Hyp-containing peptide 13c
(yellow). Key hydrogen bond interactions and distances in Å between
F-Hyp and Ser111 and His115 of VHL are shown in red; the F0−Fc
omit map contoured at 3.5 σ around the F-Hyp residue is shown in
blue. (C) Overlay of the crystal structure of peptide 13a (blue) in
complex with VBC (green) with the structure of F-Hyp in the C4-
endo conformation (orange, from small-molecule X-ray crystallog-
raphy of 4b). In black: distances in Å between the hydroxyl group of
F-Hyp in the C4-endo conformation (in orange) and the residues
Ser111 and His115 of VHL.
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pyrrolidine needs to rearrange from its predominant C4-endo
conformation to a C3-endo/C4-exo pucker that is only
modestly populated in solution, according to DFT calculations
(Table 1). This suggests that the pyrrolidine ring of the F-Hyp
in 13a must undergo a signiﬁcant change in the conformational
equilibrium to bind to the protein, possibly at the expense of
the ΔG of binding. Because only a very subtle diﬀerence in the
ΔG of binding was found between the native peptide 13c and
13a (Table 2), presumably the energetic penalty required for
the pucker rearrangement from free to bound state must be
compensated for by signiﬁcantly favorable contacts between
the protein and the ligand environment around the newly
introduced F atom.
2.4. Synthesis, Binding Aﬃnity, and X-ray Crystal
Structure of F-Hyp-Containing VHL Ligands. Encouraged
by the positive results on the binding of F-Hyp-containing
peptides to VHL, we proceeded replacing the Hyp core of the
prototypical ligand VH032 (Figure 1C, ref 39) with (3S,4S)-
and (3R,4S)-F-Hyp to study the molecular recognition within
the context of VHL ligands. Ligands 14a,b (Figure 5A) were
prepared according to previously reported procedures,38−40
and no particular optimization of reaction conditions was
required. Binding of the modiﬁed F-Hyp-containing VHL
ligands 14a,b to VBC was assessed by ITC (Table 2, Figure
5B). Ligand 14a retained nanomolar binding aﬃnity to VBC
(Table 2), which is within 2-fold of the parent Hyp-containing
ligand VH032 (Kd = 185 ± 7 nM).
39 In contrast, ligand 14b
showed a much lower aﬃnity (Table 2), corresponding to a
reduction in binding aﬃnity of almost 20-fold compared to
VH032. The ΔH of binding measured for the VHL ligands
correlated well with the binding aﬃnities.
These results conﬁrmed the trend observed for the F-Hyp-
containing peptides: the (3R,4S) isomer of F-Hyp binds to
VBC with higher aﬃnity than the (3S,4S) isomer, as a result of
diastereoselective recognition of F-Hyps. As expected, in the
case of small molecules, the diﬀerence in binding aﬃnity
between the two diastereoisomers is greater than in the case of
peptides, as the binding of such ligands relies on fewer contacts
and interactions beyond the most energetically favorable ones
involving the core hydroxyproline moiety. To elucidate the
binding mode of the two epimers of F-Hyp-containing ligands
to VHL and to rationalize the diﬀerence in binding aﬃnity, we
soaked crystals of VBC into solutions of 14a,b and solved the
crystal structures of the binary complexes. No diﬀerence in the
binding mode between the two diastereoisomers was found
(Figure 5C,D and Supp. Figure 2), and moreover the binding
mode of the nonﬂuorinated analogue (VH032) was recapitu-
lated by the ﬂuorinated analogues 14a,b. Similarly to what was
observed in the case of peptide 13a, the ﬂuorine atom in 14a
forms close contacts with an aromatic C−H of the indole ring
of Trp117 (3.2 Å), the hydroxyl group of Ser111 (3.2 Å), and
the carbonyl of His110 (3.1 Å). For 14b, close contacts
between the ﬂuorine atom and Trp117 (3.3 Å) and the
phenolic group of Tyr98 (3.0 Å) were found. The resolution of
the structures (2.7 Å for 14a and 2.3 Å for 14b) did not allow
us to unambiguously determine the ring puckering of the F-
Hyps of 14a,b, which was modeled as C4-exo, as for the
nonﬂuorinated ligand VH032 (Figure 5C,D and Supp. Figure
2). We therefore conclude that, as in the case of F-Hyp-
containing peptides, a comparably large energetic penalty must
be overcome for the ligands to bind to VHL in a C4-exo
conformation.
To provide insights into the preferential recognition of 14a
by VHL, we carried out quantum mechanics/molecular
mechanics (QM/MM) single-point energy (SPE) calculations
in a water solvation continuum, using the ligand-bound crystal
structures of VHL in complex with VH032,39 14a and 14b.
The obtained molecular electrostatic potential surfaces reveal a
markedly distinct eﬀect of ﬂuorination in the charge density
around the hydroxyproline core (Figure 6) and allow for the
rationalization of the observed preferential binding. In 14a, the
ﬂuorine induces a substantial increase in the electrostatic
potential surrounding the hydroxyl O compared to VH032 and
14b (note the yellow to red shift in Figure 6, bottom view). In
contrast, in 14b the ﬂuorine creates an electron-rich bump that
contrasts with the smaller, electron-poor surface of the H in
VH032 (note the blue to green shift in Figure 6, top view).
These alterations are anticipated to aﬀect the molecular
recognition. An increase in the electron density of the hydroxyl
group, as in 14a, would strengthen its H-bond acceptor
interaction with the side chain of Ser111. Conversely, the
bump and the inversion of the electrostatic potential induced
Table 2. Thermodynamic Binding Parameters of Peptides 13a−c and Ligands 14a,b to VBC
Kd (nM) ΔH (kcal/mol) −TΔS (kcal/mol) ΔG (kcal/mol) N.R.a
13a 12 ± 2 −10.1 ± 0.1 −0.75 ± 0.05 −10.8 ± 0.1 2
13b 52 ± 3 −9.7 ± 0.3 0.0 ± 0.2 −9.94 ± 0.04 2
13c 11 ± 1 −12.8 ± 0.1 2.0 ± 0.2 −10.9 ± 0.1 2
14a 244 ± 6 −7.2 ± 0.5 −1.8 ± 0.5 −9.02 ± 0.01 3
14b 3,080 ± 10 −3.9 ± 0.5 −3.8 ± 0.4 −7.55 ± 0.03 2
aN.R. = number of replicates.
Figure 5. Binding aﬃnity and binding mode of F-Hyp-containing
VHL ligands. (A) Chemical structure of ligands 14a,b. (B) Overlay of
ITC titration curves obtained for the F-Hyps-containing ligands 14a,b
against VBC. (C) The F0−Fc omit map contoured at 4σ (shown in
yellow) for ligands 14a,b in complex with VBC. (D) Crystal structure
of ligand 14b in complex with VBC. Key H-bond interactions are
shown in red.
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by ﬂuorine in 14b are potentially disruptive for binding
because they face the electron-rich aromatic system of Tyr98,
which is at a short distance of 3.0 Å (Figures 5D and 6) and
known to be very sensitive toward binding of small
molecules.65 These observations were consistent with MM/
generalized-Born surface area (MM-GBSA) calculations
performed using the same crystal structures (Figure 6). The
MM-GBSA interaction energy (EMM‑GBSA) of Ser111 was
higher for VHL in complex with 14a than with VH032 and
14b (ΔEMM‑GBSA = −0.6 and −1.4 kcal/mol, respectively),
whereas the interaction of Tyr98 was weakened when 14b was
bound, compared to VH032 and 14a (ΔEMM‑GBSA = +0.9 and
+0.6 kcal/mol, respectively).
We next investigated the impact of ﬂuorination on the
pharmacokinetic properties of hydroxyproline-containing com-
pounds in the context of VHL ligands 14a,b (Table 3). Despite
a small increase in LogD7.4 upon ﬂuorination, microsomal
stability of compound 14b was similar to that of the reference
compound VH032, while ligand 14a proved to be even more
metabolically stable. F-Hyp containing VHL ligands also
retained high plasma stability. We also performed a parallel
artiﬁcial membrane permeability assay (PAMPA) to measure
the passive permeability of 14a,b. The compounds exhibit
stereodependent permeability in spite of the same LogD7.4
value (Table 3), with 14a exhibiting higher permeability than
the parent nonﬂuorinated ligand VH032.
Taken together, the crystal structures of VHL in complex
with 14a,b reveal that diastereoselective recognition of 14a is
mediated by strengthening of the H-bond acceptor interaction
with Ser111, which stabilizes the less abundant C4-exo ring
pucker of the compound (Table 1). This induced ﬁt of the
ligand is reﬂected in a slight loss in binding aﬃnity of 14a
compared to the Hyp-containing ligand VH032. Instead, steric
and electronic repulsions of the ﬂuorine with Tyr98 explain the
signiﬁcant loss of binding aﬃnity in 14b. Additionally, we
found that F-Hyps-containing compounds are metabolically
stable and that ﬂuorination of Hyp increases its lipophilicity.
These positive data qualify F-Hyp VHL ligands 14a,b as
suitable cellular probes and motivated us to pursue
incorporation into VHL-targeting molecular degraders.
2.5. F-Hyp-Containing PROTACs: Eﬀect of Fluorina-
tion on Targeted Protein Degradation. PROTACs are
bivalent degrader molecules composed of a moiety that binds
an E3 ubiquitin ligase (such as VHL) linked to another moiety
that binds a target protein, such that the E3 and the target
protein are brought into close spatial proximity. This triggers
the polyubiquitylation and subsequent proteasomal degrada-
tion of the target protein, enabling post-translational
elimination of a speciﬁc gene product inside the cell (Figure
1A).
Our crystal structure of the VHL:MZ1:Brd4 ternary
complex and supporting biophysical studies have demonstrated
that productive assembly of the ternary complex ligase:PRO-
TAC:target depends on the de novo formation of PROTAC-
mediated protein−protein interactions (PPIs) between the
target protein and the ligase.45,52 These induced interactions in
the ternary complex can result in preferential recognition of a
given target protein even against members of highly conserved
protein families, in spite of using nonselective target ligands.
For instance, we have shown that a pan-selective inhibitor of
the BET protein family, JQ1, can be derivatized using the VHL
ligand VH032 to obtain a PROTAC (MZ1, Figure 1C) that is
a preferential degrader for a single member of the BET family,
Brd4. By changing the Hyp in PROTAC MZ1 with (3S,4S)-
and (3R,4S)-F-Hyps we sought to generate two epimeric F-
Hyp PROTACs (Figure 7A). These F-Hyp analogues are
expected to have identical binding modes compared to MZ1,
the same binary binding aﬃnities for the target BET
bromodomains, and extremely similar physicochemical proper-
Figure 6. Structural basis of diasteroselective recognition of F-Hyps by VHL. Molecular electrostatic potential surface of VH032, 14a, and 14b in
complex with VHL, obtained using QM/MM SPE calculations in a water solvation continuum at the MN15-L/aug-cc-pTVZ(-F) level of theory.
Tyr98 and Ser111 from VHL are shown in gray, and their interaction energy as per MM-GBSA calculations is shown below.
Table 3. Cellular Pharmacokinetics Parameters of VHL
Ligands 14a,b
mouse microsomal
stability (mL/min/g
liver)
plasma
stability T1/2
(min)
permeability
(PAMPA)
(nm s−1)
CHI
LogD7.4
VH032 0.70a >180a 1.2a 0.90a
14a <0.50 >180 2.3 1.30
14b 0.68 >180 0.81 1.30
aValues from Frost et al.40
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ties, but considerably diﬀerent binary binding aﬃnity for the
VHL ligase. We therefore hypothesized that F-Hyp analogues
of MZ1 could help to understand whether and how changing
the binary aﬃnity for one component of the ternary complex
can impact target degradation. Moreover, ﬂuorination of the
hydroxyproline core of a PROTAC may be useful to modulate
physicochemical properties of the resulting PROTAC com-
pound. We thus prepared the F-Hyp-containing PROTAC
15a,b, analogues of MZ1 (Figure 7A), which were synthesized
according to the synthetic protocol reported previously by our
group.45,46 First, we measured the binary binding aﬃnity of
15a,b for VBC and observed that, consistently with what was
found for the F-Hyps-containing peptides and VHL ligands
(Table 2), PROTAC 15a, featuring the (3R,4S) isomer of F-
Hyp, showed the highest binary binding aﬃnity for VBC
(Kd binary,VBC = 249 ± 6 nM, Supp. Table 5). PROTAC 15b was
found to be a 2.5-fold weaker ligand (Kd binary,VBC = 603 ± 74
nM, Supp. Table 5). In previous work52 we have shown that
MZ1 binds VHL and the bromodomain target proteins in a
cooperative fashion, (Kd binary,VBC/Kd ternary = α > 1) as a result
of favorable PROTAC-induced PPIs. Cooperative binding was
found also for F-Hyp-containing PROTACs 15a,b, with α
values of the system VHL:15a,b:Brd4 (α = 9.5 for 15a and α =
14.5 for 15b, Supp. Table 5) in line with the values previously
measured for MZ1 (α = 9.5−17.645,52). Together these data
are consistent with ﬂuorination of Hyp maintaining the
cooperative recognition and relative binding mode of MZ1
within the ternary complex.
Encouraged by the biophysical validation, we next
investigated to what extent F-Hyp-containing PROTACs
could induce degradation of target proteins Brd2, Brd3, and
Brd4 in cells. PROTAC 15a was able to induce potent
degradation of Brd4 (both short and long isoforms) with a
DC50 between 1 and 3 nM (Figure 7B). In contrast,
degradation of Brd2 and Brd3 occurred only at higher
concentrations (DC50 ≈ 10 nM), consistent with the
preferential Brd4 degradation documented with MZ1
degrader.46,52 Compound 15b showed a reduced potency in
terms of Brd4 degradation, with a DC50 between 10 and 30
nM. Crucially, however, degradation of cellular Brd2 and Brd3
could be observed only at the highest concentration of 15b
tested (DC50 ≈ 3 μM, Figure 7B). To evaluate the impact of
BET protein degradation on the antiproliferative activity of
BET-sensitive cancer cell lines, compounds 15a,b were tested
ﬁrst in acute myeloid leukemia MV4;11 cells (Figure 7C) and
compared with MZ1 and the inactive epimer cisMZ1.45,46
PROTAC 15a showed a marked antiproliferative eﬀect (pEC50
= 6.5), albeit weaker than MZ1 (pEC50 = 7.3), with similar
maximal response at the highest concentration used when
compared to MZ1 (Emax = 92% and 98%, respectively). In
contrast, PROTAC 15b showed a much weaker antiprolifer-
ative eﬀect compared to MZ1 or 15a, and incomplete maximal
response to baseline level was observed even at the highest
concentration tested. A similar trend was observed in a colony-
formation assay using BET-sensitive lung adenocarcinoma
A549 cells treated with test compounds for 7 days (Figure
7D). In this assay, treatment with PROTACs 15a and MZ1
resulted in profound concentration-dependent cytotoxicity,
whereas 15b aﬀected cell growth only modestly even at the
highest concentration tested. Taken together, the data support
more potent degradation activity for degraders that incorporate
the (3R,4S)-F-Hyp epimer, which is preferentially recognized
by VHL. The markedly more profound growth inhibition
activity observed between the two BET degraders investigated
here is contributed at least in part by these diﬀerences in E3
ligase-binding aﬃnities. At the same time, the data provide also
strong evidence that pan-selective degradation of all three BET
proteins Brd2, Brd3, and Brd4 leads to a much more profound
antiproliferative impact in these cancer cell lines compared to
selective Brd4 degradation, as was recently observed in other
cancer cell lines too.68 Crucially nevertheless, we show that
losing over 20-fold binding aﬃnity at one of the two binding
ends of a PROTAC still leads to eﬀective degradation of the
Figure 7. BET protein degradation induced by F-Hyp-containing PROTACs. (A) Chemical structure of PROTACs 15a,b. (B) HeLa cells were
treated with 15a or 15b and vehicle control (0.01% DMSO) for 24 h. Abundance of individual BET protein was analyzed by Western blotting using
corresponding speciﬁc antibodies after SDS-PAGE. (C) Antiproliferative activity of compounds 15a,b, MZ1, and inactive epimer cisMZ1. MV4;11
cells were treated with compounds for 72 h prior to quantitation of cell proliferation using the CellTiter-Glo luminescent cell viability assay. The
relative signal reﬂects luminescence values normalized to DMSO control. (D) A549 cells stained with crystal violet dye, following a 7-day
incubation with compounds 15a,b, MZ1, and inactive epimer cisMZ1. Dark background was added to improve legibility.
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target protein at concentrations ∼100-fold lower than the
binding Kd of the warhead ligand.
3. CONCLUSION
We devise a simple, eﬃcient, and scalable synthetic protocol
for the preparation of all four diastereoisomers of F-Hyps
starting from readily available N-Boc-4-oxo-L-proline benzyl
ester. Stereoselective ﬂuorination of the proline ring is
demonstrated when starting from N-phenylﬂuorenyl-protected
4-oxo-L-proline methyl ester. By means of computational
studies on model compounds and small-molecule X-ray
crystallography we have delineated the eﬀect of ﬂuorination
on the conformational preferences and H-bond donor capacity
of the Hyp core. Hydroxyproline has a crucial role in structural
proteins, e.g., collagen and elastin, and cell signaling pathways
such as hypoxic response. Conformational control in proline
systems is thus a subject of intense investigation, with
important biological and technical applications. Our discovery
that ﬂuorination of Hyp inverts the natural preference from the
C4-exo pucker to the C4-endo pucker could have unforeseen
applications in protein engineering, e.g., enabling design of new
molecular switches based on F-Hyps.
Hydroxyproline-containing VHL-hijacking PROTACs are
being considered as clinical candidates. Because the hydrox-
yproline moiety is absolutely critical for molecular recognition,
all VHL ligands known to date contain the natural amino acid.
The discovery that VHL can also recognize stereoselectively
the (3R,4S) epimer of F-Hyp represents an important step
forward by expanding the chemical space of chemical
degraders. Incorporation of the weak-aﬃnity (3S,4S) epimer
of F-Hyp induced target-selective degradation at concen-
trations over 2 orders of magnitude lower than the binary Kd
for VHL. This realization has important implications for drug
design of degraders where only weak-aﬃnity binding ligands
may be available, for example, against poorly ligandable targets.
It is expected that the structure−activity relationships
extensively delineated for Hyp-containing VHL ligands38−40
should directly translate upon F-Hyp replacement, thereby
allowing expansion of chemical space while ﬁne-tuning
molecular and pharmacokinetic properties of VHL inhibitors
and VHL-targeting PROTACs. The structural, binding, and
cellular PK characterization of F-Hyps and proof-of-concept
application as chemical tools disclosed in this work together
qualify F-Hyps as useful building blocks for incorporation in
future small molecules of medicinal relevance and to probe cell
biology. They also provide a blueprint to pursue other
ﬂuorohydrin-containing molecules that could inspire new
applications to small-molecule discovery.
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